Parathyroid disorders and calcium imbalance: Pathology review

16,139views

Parathyroid disorders and calcium imbalance: Pathology review

G3n3tics to add

G3n3tics to add

Legg-Calve-Perthes disease
1p36 deletion syndrome: Year of the Zebra
Cleidocranial dysplasia
Developmental dysplasia of the hip: Clinical sciences
Collagen disorders: Pathology review
Approach to connective tissue disorders: Clinical sciences
Fetal alcohol syndrome
Rett syndrome
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Approach to aneuploidies and microdeletions: Clinical sciences
Approach to inborn errors of metabolism (acute): Clinical sciences
Approach to inborn errors of metabolism (progressive or chronic): Clinical sciences
Approach to neurocutaneous syndromes: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Approach to primary immunodeficiencies: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Sickle cell disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to atypical genitalia: Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to short stature: Clinical sciences
Obesity (pediatrics): Clinical sciences
Congenital cytomegalovirus (NORD)
Chiari malformation
Seizures and epilepsy
Approach to epilepsy: Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Early infantile epileptic encephalopathy (NORD)
Spinocerebellar ataxia (NORD)
Sturge-Weber syndrome
Spina bifida
Von Hippel-Lindau disease: Year of the Zebra 2024
Neurocutaneous disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Development of the digestive system and body cavities
Development of the fetal membranes
Development of the placenta
Development of the umbilical cord
Development of twins
Hedgehog signaling pathway
Ectoderm
Endoderm
Mesoderm
Development of the cardiovascular system
Fetal circulation
Development of the eye
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the limbs
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Peutz-Jeghers syndrome
Autism spectrum disorder
Autism spectrum disorder: Clinical sciences
Developmental and learning disorders: Pathology review
Learning disability
von Hippel-Lindau disease
Muscular dystrophies and mitochondrial myopathies: Pathology review
Fatty acid oxidation
Fatty acid synthesis
Classical homocystinuria (NORD)
Homocystinuria
Alkaptonuria
Cystinuria (NORD)
Hartnup disease
Maple syrup urine disease
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Essential fructosuria
Galactosemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hereditary fructose intolerance
Lactose intolerance
Pyruvate dehydrogenase deficiency
Abetalipoproteinemia
Familial hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Fabry disease (NORD)
Gaucher disease (NORD)
Krabbe disease
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Niemann-Pick disease type C
Niemann-Pick disease types A and B (NORD)
Tay-Sachs disease (NORD)
Cystinosis
Disorders of amino acid metabolism: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Approach to hypothyroidism: Clinical sciences
Hypothyroidism medications
Hyperthyroidism medications
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Hyperthyroidism
Hyperthyroidism: Pathology review
Hashimoto thyroiditis: Clinical sciences
Thyroid nodules: Clinical sciences
Multiple endocrine neoplasia: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Hypopituitarism: Pathology review
Growth hormone deficiency
Congenital adrenal hyperplasia
Atrial septal defect
Coarctation of the aorta
Patent ductus arteriosus
Ventricular septal defect
Hypoplastic left heart syndrome
Tetralogy of Fallot
Total anomalous pulmonary venous return
Transposition of the great vessels
Persistent truncus arteriosus
Cyanotic congenital heart defects: Pathology review
Acyanotic congenital heart defects: Pathology review
Congenital renal disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Congenital neurological disorders: Pathology review
Congenital TORCH infections: Pathology review
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Introduction to the immune system
MHC class I and MHC class II molecules
VDJ rearrangement
Antibody classes
Ataxia-telangiectasia
DiGeorge syndrome
Wiskott-Aldrich syndrome
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Adenosine deaminase deficiency
Hyper IgM syndrome
Complement deficiency
Chronic granulomatous disease
Leukocyte adhesion deficiency
Thymic aplasia
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Cornelia de Lange syndrome: Year of the Zebra
Alagille syndrome (NORD): Year of the Zebra
Alkaptonuria: Year of the Zebra
Alpha-1 antitrypsin deficiency: Year of the Zebra 2024
Chopra-Amiel-Gordon syndrome: Year of the Zebra 2024
FOXG1 syndrome: Year of the Zebra
Gaucher disease (NORD): Year of the Zebra
Gorlin syndrome: Year of the Zebra
Leprosy: Year of the Zebra
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Year of the Zebra
Nail-patella syndrome: Year of the Zebra
PGAP3-congenital disorder of glycosylation: Year of the Zebra
Phenylketonuria (NORD): Year of the Zebra
Pierre Robin sequence: Year of the Zebra
Retroperitoneal fibrosis: Year of the Zebra
Sanfilippo syndrome: Year of the Zebra
Shwachman-Diamond syndrome: Year of the Zebra
Turner syndrome: Year of the Zebra
Andersen-Tawil syndrome: Year of the Zebra 2025
Peroxisomal disorders: Pathology review
Cytoskeleton and elastin disorders: Pathology review
Epidermolysis bullosa: Year of the Zebra
Gorlin syndrome (Gorlin Syndrome Alliance)
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Cystic fibrosis: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Gastroschisis
Omphalocele
Approach to abdominal wall defects: Clinical sciences
Early pregnancy loss: Clinical sciences
Pyloric stenosis: Clinical sciences
Pyloric stenosis
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Intestinal atresia
Hirschsprung disease
Hirschsprung disease: Year of the Zebra
Alagille syndrome (NORD)
Renal agenesis
Bladder exstrophy
Horseshoe kidney
Hypospadias and epispadias
Potter sequence
Posterior urethral valves
Renal tubular acidosis
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes insipidus
Diabetes insipidus: Clinical sciences
Breast cancer: Pathology review
Breast cancer
Breast cancer screening: Clinical sciences
Colorectal polyps and cancer: Pathology review
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Familial adenomatous polyposis
Multiple endocrine neoplasia: Clinical sciences
Fanconi anemia: Year of the Zebra 2025
Desmoid Tumor (NORD)
Multiple endocrine neoplasia
Oncogenes and tumor suppressor genes
Necrosis and apoptosis
Charcot-Marie-Tooth disease
Spinal muscular atrophy
Precocious puberty
Delayed puberty
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Kallmann syndrome
Puberty and Tanner staging
Amenorrhea
Hydronephrosis
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Beta-thalassemia
Von Willebrand disease
Protein S deficiency
Factor V Leiden
Protein C deficiency
Antithrombin III deficiency
Zellweger spectrum disorders (NORD)
Glycogen metabolism
Hemochromatosis: Clinical sciences
Lesch-Nyhan syndrome
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Adrenoleukodystrophy (NORD)
Alzheimer disease: Clinical sciences
Alzheimer disease

Transcript

Watch video only

On the Endocrinology ward, two individuals came in. The first person is 47 year old Melania who recently went through a surgical procedure called thyroidectomy due to thyroid cancer. Melania came in with tetany and on the clinical examination, there was a positive Chvostek’s sign. The other person is 55 year old Emma, who came in with constipation, muscle weakness and bone pain. She has a history of kidney stones, specifically calcium stones and she also said that she’s been feeling down lately. Calcium, phosphate and PTH levels were taken in both individuals. Melania had low levels of calcium, high levels of phosphate and low levels of PTH, whereas Emma had high levels of calcium, low levels of phosphate and high levels of PTH.

Both individuals seem to have a problem in their parathyroids. First, a bit of physiology. The 4 parathyroid glands are on the posterior of the thyroid gland, and their main job is to keep blood calcium levels stable. Changes in the body’s levels of extracellular calcium and phosphate levels are detected by surface receptors in the parathyroid’s chief cells. Both decreased calcium levels and increased phosphate levels can signal the chief cells to release more parathyroid hormone or PTH. PTH affects many organs. In the bones it binds to osteoblasts, the bone building cells, and causes them to release RANK ligands, or RANK-L, and monocyte colony-stimulating factor, or M-CSF. These will cause osteoclast precursors to mature into osteoclasts that break down bones and release calcium and phosphate into the blood. PTH also gets the kidneys to reabsorb more calcium and excrete more phosphate. It also activates calcitriol, also known as 1,25-dihydroxycholecalciferol, or active vitamin D. Active vitamin D then goes on to cause the gastrointestinal tract to increase calcium absorption. Altogether, these effects help to increase extracellular levels of calcium with they’re low.

Now, let’s talk about hypoparathyroidism, where there’s an abnormality with the parathyroid glands so PTH levels are low. The most common cause is removal of the parathyroid glands during thyroid or parathyroid surgery. Another cause is an autoimmune condition that destroys parathyroid glands. There are also genetic causes like DiGeorge syndrome that causes a variety of immune and birth defects. With DiGeorge syndrome, the 3rd and 4th pharyngeal pouches don’t develop, so the parathyroid glands and thymus that originate here will be missing in the infant. Then there is pseudohypoparathyroidism, where PTH levels are normal or high, but the kidneys and bones don’t respond to PTH and this is called PTH resistance. An example is pseudohypoparathyroidism type 1A, or Albright hereditary osteodystrophy, which is an autosomal-dominant condition. The cause is a mutation in the Gs protein alpha-subunit and this mutation is inherited from the mother. Gs proteins function as cellular signaling proteins and where there’s a defect in the alpha-subunit, in this case, the PTH receptor in the bones and kidney won’t be able to activate and so PTH can’t exert its effects. With Albright osteodystrophy, classical symptoms include shortened 4th and 5th digits, short stature, obesity and developmental delay. Now, there’s also pseudo-pseudohypoparathyroidism, which is a subtype of Albright’s hereditary osteodystrophy and it also include symptoms like brachydactyly, developmental delays, and short stature. However, the gene is passed on by the father instead of the mother and there’s no PTH resistance, so there’s normal PTH and calcium levels.

Now let’s look at the symptoms caused by low levels of parathyroid hormone or the lack of response to them. Both will lead to hypocalcemia and hyperphosphatemia which results in more excitable neurons. This can lead to tetany, or the involuntary contraction of muscles. The spontaneous firing of neurons leads to Chvostek's sign, which is when facial muscles twitch after the facial nerve is lightly tapped, usually 1 cm below the zygomatic process. It can cause Trousseau's sign, which is where a blood pressure cuff applies pressure on the brachial nerve which is enough to make it fire, resulting in a muscle spasm that makes the wrist and metacarpophalangeal joints flex. If the hypocalcemia and hyperphosphatemia are severe, this can lead to life-threatening complications like severe seizures and cardiac arrhythmias.

Let’s move on and talk about hyperparathyroidism. There are three types of hyperparathyroidism; primary, secondary, and tertiary. In primary hyperparathyroidism, the parathyroid gland is responsible for the problem, because it makes parathyroid hormone independently of the calcium level. Most often, primary hyperparathyroidism is caused by a parathyroid adenoma, a benign tumor. Rarely, primary hyperparathyroidism is caused by hyperplasia, where parathyroid cells divide excessively causing growth of the glands and in very rare cases, there can be a carcinoma of the parathyroid glands.

The symptoms of primary hyperparathyroidism can be remembered, especially for exams, as ‘stones, thrones, bones, groans, and psychiatric overtones’. Now, hyperparathyroidism causes hypercalciuria, which can lead to dehydration and can stimulate the formation of calcium based kidney stones and gallstones. Thrones refers to the toilet to remind you of the polyuria or frequent urination that results from impaired sodium and water reabsorption. Bones is for bone pain that results after chronic hormone-driven demineralization in order to release calcium. Groans is for constipation and muscle weakness, both of which are partly due to decreased muscle contractions. The excess calcium makes neurons less excitable, which leads to slower muscle contractions, and diminishes neuron firing in the central nervous system. As a result, there are psychiatric overtones which refers to symptoms like depression and confusion. In addition, excess PTH will cause osteoclasts to break down bone and makes the kidneys hold on to calcium and get rid of phosphate, resulting in hypercalcemia and hypophosphatemia. Eventually, bone resorption by osteoclasts can lead to a condition called osteitis fibrosa cystica, where there are cystic bone spaces that are filled with osteoclasts and hemosiderin and these are called brown tumors. Classic signs include subperiosteal erosions that affects the phalanges in the fingers, and salt and pepper sign in the skull, which refers to the numerous small lesions caused by bone resorption. Osteitis fibrosa cystica is classically associated with primary hyperparathyroidism, but can be seen sometimes with secondary hyperparathyroidism, too.

With primary hyperparathyroidism, labs show hypercalcemia, hypophosphatemia, high levels of PTH, high alkaline phosphatase or ALP due to increased bone resorption, and high levels of cAMP in the urine due to hypercalcemia.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Textbook of Medical Physiology" Elsevier España (2006)
  4. "Davidson's Principles and Practice of Medicine" Churchill Livingstone (2010)
  5. "Primary, Secondary and Tertiary Hyperparathyroidism" Springer (2015)
  6. "Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus" Osteoporosis International (2016)
  7. "Hypoparathyroidism" New England Journal of Medicine (2008)